Phase III Trial of BI 695502

A multicenter, randomized, double-blind Phase III trial to evaluate efficacy and safety of BI 695502 plus chemotherapy versus Avastin® plus chemotherapy in patients with advanced nonsquamous Non-Small Cell Lung Cancer.

11480 Brookshire Ave #309
Downey
CA
90241
United States
562-869-1201